First Of Its Kind Pharmacokinetics Study On Cannabinoids For Dogs
Cornell University’s College of Veterinary Medicine has just announced the findings of the first-ever pharmacokinetic clinical trial on the effects of cannabinoids for dog pain.
The participating dogs in the study were suffering from multi joint pain and osteoarthritis. To conduct the 8-month double blind, placebo controlled study, Cornell collaborated withElleVet Sciences. ElleVet Sciences was founded in Portland in 2017, and is in the business of creating soft-chew supplements for dogs made from proprietary hemp oil blends.The primary goal of the Cornell-ElleVet study was to understand how dogs metabolized ElleVet Mobility soft chews, which are hemp-based supplements also containing glucosamine and chondroitine, two natural compounds that may improve mobility in dogs with arthritis. Glucosamine and chondroitin are already being widely used by arthritic humans.Read More »